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Abstract
This project will investigate novel amino acid methyl ester chiral ionic liquids and
determine how increased concentration of lanthanide solute and changes in size of
counter ions tetramethylammonium and tetrabutylammonium affects interaction between
the ionic liquid and the fluorescent lanthanide solute. Both concentration dependence and
temperature dependence were discovered. The chiral ionic liquid [L-prolineCl][TfiN]
reacted uniquely to the change in concentration.
3
1 Introduction
1.1 Background
A chiral molecule, in its most basic terms, is a species with a non-superimposable mirror
image. Human hands are an example of this as they are mirror images of one another but
not stackable (i.e. not super imposable). The left hand and right hands are chiral
enantiomers of one another. Chiral molecules are important to many areas of chemistry,
one being biochemistry. This importance is seen by the overwhelming abundance of a
single enantiomer in nature. Floudas et al.J searched the protein database and revealed
that over 99% of proteins are made of a single amino acid enantiomer. This finding is
synonymous to saying that in nature everyone has only his or her left hand, and the right
hand is less important or even detrimental. Chirality also plays an important role in drug
formulation. The metabolism of certain drugs can be affected by a single chiral
difference, as noted by Pham-Huy et al.2 Because of lowered potency or detrimental
health outcomes associated with some chiral molecules separation of the enantiomers is
often crucial. One way to effectively separate or inf1uence chirality may be through the
use of chiral ionic liquids.
Chiral ionic liquids (CILs) have many purposes both in analytical chemistry and catalyst
chemistry. They have useful properties' in analytical chromatograph/ such as being
thermally stable, homogeneous and reusable. CILs have also been used in
electrochemical'' techniques to study complex samples. Other chemists have found CILs
useful in entioselective or asymmetric reactions, allowing a single chiral enantiomer to be
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formed6• It is the purpose of this thesis to investigate how CIL solvents influence solutes
chiral equilibrium, forming asymmetric solutions.
Chiral amino acid methyl ester derived chiral ionic liquids were used in this study. The
CILs are composed of the cations and anion shown in Figure 1.1.1 below. The cations are
based on amino acids, which are the building blocks oflife and chiral. We used the
methylated monomer in these CILs with a common ionic liquid anion
bis(trifluoromethanesulfonimide), [Tf-N]. Using the methyl ester form allowed for the
amino acids to have a positive charge for a larger pH region. The cationic nature of the
amino acid methyl esters is important as it allows for the amino acid methyl ester to be
attracted and surrounded by negatively charged anions. These amino acid methyl esters
when combined with [TtzN] provide a CIL that can be used as the solvent for different
solutes.
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Cation Anion
[ "'C~OC",l
NH3
L.alanine methyl ester = Lvalaninef.!
"'C~OC"'B
NH3
D.alanine methyl ester = Dvalaninef"!
H3C~ ............... .1'I ~ 'OCH3
CH3 NH3
L.leucine methyl ester = L·lelicineC I
Lvproline methyl ester = L·prolineCI
Figure 1.1.1: Amino acid methy I ester cation' s (left), anion
bis(trifluoromethanesulfonimide) on the right. Displayed using ChemDraw.
1.2 Europium Complex
To study how the CIL affects solutes dissolved in it we employed a fluorescent europium
complex, [Eu(dpau]" (dpa= 2,6-pyridineicarboxilate dianion), shown below in Figure
1.2.1. [EuCdpaji]" is a lanthanide metal complex having a propeller blade like
configuration. The direction of the propeller blades determines the handedness or
chirality of the complex. Three dimensionally this is recognized as a right or left hand
rotation. The right and left hand conformations are enantiomers of one another. Figure
1.2.3 shows both of these conformations connected with a racemization double arrow.
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Racemization process occurs through the labile rotation of the ligands around the
europium metal core. The left complex shows a propeller blade that would follow the left
hand rule, where the leading wedge bonds follow a clockwise rotation making that
complex lambdoid chirality and [11-Eu(dpa)3f Lanthanide metal complexes have
strong emission bands and therefore can often be employed for spectroscopic
measurements.t The complex uses the dpa's conjugated system as excitation antennae to
absorb more radiation and allow for europium electronic transition. Following this
electronic transition the europium center is left in an excited state. The relaxation process
often involves the emission of a photon of light defined by a certain chiral rotation, and
deemed circularly polarized. Circular polarized light is shown in Figure 1.2.2, where the
emission from the different enantiomers causes the two different light rotations. The
circular polarization is determined by the chiral conformation, or handedness, of
[Eu(dpaht·
3-
Figure 1.2.1 [Eu(dpaji]" shown in flat skeletal structure using ChemDraw.
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Figure 1.2.2: The two rotations observed with circular polarized light. Obtained under the
Wiki creative commons license.
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Figure 1.2.3: Conformation equilibrium obtained by [Eu(dpaj.]" in the ClL. Left:
[11-Eu(dpa)3]3-; Right: [,1 +Eutdpajj]",
The ClL can have interact with the large [Eu(dpa)3f molecule forming many different
transitory structures. Of these many different structures or orientations, there are some
more probable than others. Some of these probable interaction points are the symmetry
axis found in the europium complex. A symmetry axis is an axis that can be rotated n
times at 360/n degrees yielding an identical image at each step in the rotation. These
symmetry axes are seen in both conformations of the chiral complexes. Figure 1.2.4
shows both of the symmetry axis in the [,1 - Eu( dpajj]" complex. The left image shows a
C3 symmetry axis, where the molecule can be rotated 120" three times, yielding the
8
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identical structure at each step, while the left structure shows a C2 axis (two 1800
rotations ).
Figure 1.2.4: [.1 -Eu(dpa)3t shown aligned with the symmetry axes present in the
molecule. Left structure shows the C3 axis and the right structure shows the C2 axis.
The molecules that surround the europium complex, such as the ClLs, can influence the
chiral conformation of the complex. Because lanthanide complexes form labile but
constant connections with their ligands, chiral changes can occur through rotation of the
ligands, changing the configuration of the propeller blades. The propeller blades rotate at
the europium metal center forming each enantiomer.
Further, Huskowska et al.8 used chiral sugars to influence a similar lanthanide probe,
[Tb(dpa)3t. They argue the racemization process occurs rapidly in non-viscous
solutions. Yoneda et al. 9showed how sugars with differing chiral centers affected the
chiral equilibrium of the two enantiomers presented in Figure 1.2.3. Viscosity and
chirality seem to both be playing an important role in the racemization of lanthanide
complexes.
Kroupa et al.IO found that the CIL solvent, both viscous and singularly chiral, imposes a
perturbation on the the racemization of [Eu(dpa)3]3-. Kroupa also found [D-
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alanineCl][TfzN] causes the conformation and thus emission of the europium complex to
be opposite that of the emission seen by the complex in [L-alanineCl][Tf2N]. The
changes in conformation seen while using the europium complex can be considered an
equal but opposite equilibrium perturbation imposed by each of the CIL solvents. They
determined the CIL solvents increased either the amount of left-handed (A) or the right-
handed (~) europium complex in equilibrium.
One way to study these changes in the chiral equilibrium is to measure the relative
amounts of rotated light. This can be accomplished through measuring circular
dichroism II (CD) or circular polarized luminescence (CPL)12. Both techniques allow
measure of the population of circularly polarized light. CD uses circular polarized light
absorbance, and relates an increase in absorbance to the amount to the increase of a
particular chiral center. CD, however, often suffers from poor sensitivity. CPL uses a
probe, like [Eu(dpa)3t, to emit circular polarized light. CPL measurements relate the
population of rotated light to the amount of each chiral conformation, or enantiomer, in
the solution. As the amount of the measured light changes between liquids it is important
to develop a means to compare them. In CPL spectroscopy'r' this comparison factor is
termed a dissymmetry factor, known as a gem.
Using CPL spectroscopy the difference in the polarized light must be measured,
designated tV (/I.). The difference in polarized light is then related to the dissymmetry
factor through equation 1.1 where differences of each samples total emission are
10
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accounted for. The total light intensity is noted as leA). The dissymmetry factor can be
calculated as follows:
1.1
Again, the dissymmetry factor is used to find the perturbation of the chiral equilibrium
when using CPL spectroscopy.
Finding the ratio of the chiral enantiomers involves relating the dissymmetry factor to the
enantiomeric excess, termed 1]. The enantiomeric excess is the concentration and is fond
by dividing the polarized light observed, gem (A), by the total possible polarized light,
g~m (A), as shown in equation 1.2. Kroupa et al. 14 provided the total possible polarized
light as g~m (A) = 0.29. The enantiomeric excess is the ratio of measured dissymmetry
factor to the total possible dissymmetry factor. The enantiomeric excess can be related to
the population of each enantiomer in solution.
1.2
The enantiomeric excess allows for further calculation of the racemization equilibrium
constant Krac. An equilibrium constant can be calculated for reaction 1.3 where the
equilibrium constant is effectively the ratio of enantiomers. The equilibrium constant
from equation 1.3 is represented as the equilibrium constant, Krac, and is defined in
equation 1.4.
1.3
11
A - [Eu(dpa)3P-K =----,,--;__-=...:.-
rae Ll - [Eu(dpa)3P- 1.4
Calculation of Kracis completed using the enantiomeric excess values determined in
equation 1.2. The enantiomeric excess is used to give the Kracin equation 1.5:
K _ A - [Eu(dpa)3P- 1+ 1]
rae - Ll - [Eu(dpa)3P- 1 - 1]
1.5
Following the determination of the Kracit is also possible to determine the enthalpy of the
racemization reaction, ~Hrac. The ~Hrac is the energy released or required for the
proposed racemization to occur. A negative ~Hracmeans it is an exothermic process and a
positive means that the process is endothermic. This value is calculated using a Van't
Hoff plot, with the natural log of the equilibrium constant as the vertical axis and the
inverse temperature as the horizontal axis. The slope of this line is the ~H divided by the
gas constant, R, as shown in equation 1.6.
LlH 1 LlS
InK =---+-rae R T R 1.6
1.3 Pfeiffer Effect of Chiral Discrimination
If chiral compounds are synthetically formed without any sort of favored chiral
conformation they will be made racemic, 50:50 mixtures. That racemic formation is seen
for [Eu(dpa)3]3- when originally formed. That racemization mechanism forms equal
amounts of CPL emitted from [Eu(dpaj-]" in an achiral solution, a solution lacking a a
chiral influence. However, if a molecule in the solution has a fixed chiral influence we
find that the originally 50:50 equilibrium of enantiomers is perturbed. The induced shift
in a chiral equilibrium, Figure 1.2.3, is known as the Pfeiffer effect'5, 16.
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The Pfeiffer effect is the formation of a non-racemic mixture by the influence of a
environment of molecules that is chiral. Adding a chiral environment can induce optical
activity, or perturb equilibrium. Within the Pfeiffer effect literature'? there are two
proposed mechanism for this dissymmetry, associative and dissociative. The associative
mechanism proposes that the chiral environment is totally associated with the inf1uence
molecule that is being monitored. This would propose a static complex of [Eu(dpa)3]3-
with CIL molecules locked in a specific formation. The dissociative mechanism proposes
that the chiral environment is not directly associated with the influenced molecule that is
being monitored. A dynamic fluid movement of chiral environment around the
[Eu(dpa)J]3- is proposed, where the chiral environment-europium complexes do not form.
Wu et al. 18 gives evidence supporting the dissociative model when using L-histidine with
[Tb(dpa)J]3-.
An associative mechanism would involve the CILs forming a stabilizing structure around
the ligands of the europium complex. The ligands would be more stabilized in one
conformation, and perturb the equilibrium in that direction. Brittain et al. 19 shows
different chiral phenylalkylamines, phenylalkylamino alcohols and phenylalkylamino
acids could form stabilizing interactions, through an associative Pfeiffer effect using a
similar lanthanide complex, [Tb(dpa)3]3-. Crucially different between the previous study
and the current work is the identity of the chiral effector. The chiral effector in the
previous study was a co-solute while in the current thesis is the solvent. Brittain similar
study focuses on using only micro amounts of the chiral effector. The effect of a chiral
solvent on the [Eu(dpaj-]" probe is the focus of this work.
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1.4 Summary:
CILs have many uses throughout a diverse range of chemistry fields, one being their
ability to impose chiral perturbation. This study looks at the chiral perturbation of
[Eu( dpaj-]" racemic equilibrium using circular polarized luminescence spectroscopy. It
will investigate how changes to [Eu(dpa)3]3- concentration effect the degree of
equilibrium perturbation, with hopes to draw conclusions on how the CIL interacts with
the emitting complex (Pfeiffer effect). Finally, using van't Hoff plots the heat of reaction
will be investigated.
2 Method and Materials
2.1 Preparation of Chiral Ionic Liquids
L-Alanine methyl ester hydrochloride (MW: 139.58 glmol, L-alanineCl), D-Alanine
methyl ester hydrochloride (MW: 139.58, D-alanineCl), L-Proline methyl ester
hydrochloride (MW: 165.62 glmol, L-prolineCl), L-Leucine methyl ester hydrochloride
(MW: 181.66 glmol, L-leucineCl), and Bis(trifluoromethane) sulfonamide lithium
([Tf2N]Li) salt (MW:287.09 glmol, [Tf2NT) were all purchased from Sigma Aldrich and
used without further purification. Molar equivalents of a single amino acid methyl ester
hydrochloride and [T6N]Li were stirred in separate beakers using approximately 3mL
deionized water. After dissolving each of the solids, the solutions were mixed and
allowed to stir for approximately 10 minutes or until micelles of chiral ionic liquid (CIL)
began to form. This solution is then transferred to a separatory funnel for separation of
the CIL layer from aqueous layer. The mixture is allowed to sit for two to three days
before collection of CIL. After collection the CIL layer is dried in a vacuum desiccator
for three or more days.
2.2 Preparation of [Europium(2.6-pyridinedicarboxylate dianionhlX3 (X=[TMA1+ or
[TBA1+):
Europium (III) chloride hexahydrate (EuCh-6H20, MW: 366.41 g/mol), 2,6-
pyridinedicarboxylic acid (dpa, MW: 167.12 g/mol), tetramethylammonium hydroxide
solution ([TMAt, MW: 91.15), and tetrabutylammonium hydroxide solution ([TBAt,
MW:259.47 g/mol) were all purchased from Sigma Aldrich and used without further
purification. EuCh-H20, 1 equivalent, is dissolved in water, and later 3 equivalents of
NaOH was used to precipitate Eu(OH)3' The solid is filtered. 2,6-pyridinedicarboxylic
acid (dpal-L) is added drop wise to the filtered Eu(OH)3 to reach a neutral pH, roughly 3
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molar equivalents. To the [Eu(dpa)3t solution 3 molar equivalents of [X][OH] is added,
precipitating [Xh[Eu(dpa)3]. Solvent was removed by heating «60°C) under vacuum for
approximately 2 hours leaving a white crystalline and amorphous solid for
[TMAh[Eu(dpa)3] (856.86 g/mol) and [TBAh[Eu(dpa)3] (1374.68 g/mol), respectively.
2.3 Sample Preparation
Concentration dependence was determined by separately adding each complex to each
CIL so that the final millimolality was 0.1 mm, 0.2 mm, 0.3 mm, 0.4 mm, 0.5 mm, and
0.6 mm. Mass by difference was completed using Mettler-Toledo analytical balance. For
example if making 0.4 mm concentration of [TMA h[Eu( dpaj-] 0.00051 g of the
europium complex would be added to a glass vial. Following this approximately 1.5 g of
a CIL is added allowing for the correct final concentration. Mass measurements are taken
at every step in the combination allowing for accurate concentration determination.
2.4 Circular Polarized Luminescence (CPL) Measurement
The measurement were completed using a custom-built CPL spectrometer, which
consists of a 450W Xenon arc lamp, monochromator, photoelastic modulator (Hinds
PEM-80), a linear polarizer, a high-resolution monochromator (Horiba Johin Yvon
iHR320), and red-sensitive photomultiplier tube (PMT, Hammamatsu R928). White light
from the Xenon arc lamp was passed through a time resolving chopper an initial filtering
monochromator, isolating 280nm light. This light was directed towards the sample
cuvette that is 90° from the following spectrographic components. Following sample
excitation and emission, light was filtered allowing for selective passage of uniquely
rotated light through the PEM and is then passed to the high-resolution monochromator
for selection and subsequent detection over the 585-600nm wavelength range. The signal
output from the PMT was processed by a lock-in amplifier, which reduces background
electrical noise. Electrically resolved data is collected using LabView® software and
stored on laboratory computer. Data was stored in the form of chiral resolved intensity
and the total intensity for chiral influence determination. Variable temperature
dependence studies were also completed on the varied concentration samples.
Temperature control was completed using a heated/cooled water bath that cycles through
the sample housing.
2.5 Lifetime Measurement
Luminescence lifetime decay measurements were completed on previously described
instrument. Time resolving chopper modulated light at 90 Hz and selected 280 nm
monochromatic light was focused onto the sample. Lifetime measurements were
collected using PEM-80 linearized light and the high-resolution monochromator
measuring emission at 614 nm. Linear polarization from PEM-80 was optimized for
monochromator detection allowing high signal sensitivity. Signal averaging was
completed using approximately 1000 scans processed by the oscilloscope, collected using
LabView ® designed software, and was stored on laboratory computer.
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2.6 Emission Spectra
Sample emission spectra were obtained using a Perkin Elmer LS55 spectrophotometer in
both fluorescent and phosphorescent scan mode. Fluorescent scan mode measured the
immediate emission of light caused by fast relaxation of the excited europium complex.
Phosphorescent scan mode collected emission spectra after a brief delay allowing for the
forbidden relaxation events to be measured, and was used. Excitation wavelength was set
at 280nm. Emission was measured over 500-650 nm wavelength range.
2.7 Karl-Fischer Titration
Karl-Fischer titration was used to measure water content of the CIL's prior to addition of
the europium complex and the CPL measurement. A small amount (-0.010 g) of CIL was
drawn into a syringe and then dispensed into the electrolytic cell. Mass by difference
using the syringe allowed calculation of mass that was used in the Karl-Fischer titration
analysis of water content.
3 Results and Discussion
3.1 Experimental Interpretation
Emission spectra of the europium complex were measured in each CIL before further
tests were completed. The spectra allowed confirmation that the [Eu(dpah][TMAh
complex had not decomposed as it was heated and mixed with the CIL. The emission
scan has two clear peaks at -595 nm and 615 nm, caused by the 5Do~ 7FJand 5Do ~ 7F2
electronic transitions, see Figure 3.1.1 and 3.1.2. The 595 nm peak should contain a weak
shoulder at 588 nm, which is descriptive of the lanthanide in complex with the three-dpa
ligands. If the lanthanide complex decomposed then the emission scan would not have
shown the shoulder at approximately 590 run.
16
15
Q)
oc
Q) 10o
(/)
Q),_
0
:J
u::::
5
580 590 600 610 620 630
Wavelength (nm)
Figure 3.1.1: Fluorescence emission spectra taken using the Perkin-Elmer LS55 on 0.4
mm [Eu(dpa)3][TMAh in [D-alanineCl][Tf2N].
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Figure 3.1.2: Phosphorescent emission spectra taken using the Perkin-Elmer LS55 of 0.4
mm [Eu(dpa)3][TMAh in [D-alanineC1][Tt2N].
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A phosphorescence spectrum, not a fluorescence spectrum, was used for structural
confirmation. The fluorescence spectrum, shown in Figure 3.1.1, had a sloping baseline
and high background signals. The increased background noise was influenced, most
likely, by the purity of the ionic liquid. The phosphorescent scan mode on the Perkin-
Elmer LS-55 conditioned the signal by running an optimizing phototube dark current and
capturing the spectra after a short time delay, Figure 3.1.2. The delay resolved the
phosphorescence spectrum from the noise present in the fluorescence spectrum.
Fluorescence scans occur directly following the excitation and contain many radiative
relaxations. A short delay postpones measurement until the non-descriptive radiative
relaxations had occurred and only the descriptive lanthanide radiative decays remained.
Descriptive lanthanides electronic transitions were selectively measured by the LS50 in
the phosphorescence scan mode. The phosphorescent spectra allowed us to conclude that
the europium complex is still intact in the Cll..
18
0.8
0.7
0.6
~ 0.5'wc:
Q)
C 0.4
0.3
0.2
0.1
ChiA2/DoF = 0.00003
R'2 = 0.99906
yO 0.08864
A1 0.72241
±0.00085
±0.00073
±0.00662t1 2.08143
o 2 3 54
t (ms)
Figure 3.1.3: Fluorescent lifetime measurement for the [Eu(dpaj-] [TMAh probe in [L-
alanineC 1][Tf2N] CIL.
Lifetime measurements were completed for the europium complex in each CIL. A
lifetime measurement, see Figure 3.1.3, was used to check the local environment of the
lanthanide complex. In each sample the lanthanide complex was closely interacting with
solvent molecules. These molecules were primarily the CILs and trace amounts of H20.
The interaction makes it possible for energy to be transferred to the solvent molecules
surrounding the complex. The energy transferred to those molecules was then allowed to
decay on its own, often through non-radiative decays. The monitoring of the excited state
lifetime can be used to search for differences in the water content, solvation, and other
microenvironment changes around the lanthanide complex in each sample.i" 21 The
lifetime emission could also be characterized to the europium complex in H20, allowing
further structural conformation.
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The lifetime scans allowed for the actual lifetimes to be calculated by fitting the raw data
to an exponential decay. The lifetimes varied between 1.5 ms and 2.1 ms, but did not
seem to be correlated to the concentration of the europium complex. Trends would have
ideally indicated differences in the microenvironments surrounding the europium
complex. Water concentrations were determined throughout the study using a Carl-Fisher
titration apparatus, and no correlations between lifetime and percent H20 were found. All
water content was kept low by storing the samples in a vacuum desiccator up to analysis.
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Figure 3.1.4: TL (black) and CPL (red) scans for 0.3 mm [Eu(dpa)3][TMAh in [L-
alanineC 1][Tf2N] CIL.
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Prior to calculating the dissymmetry both a total luminescence (TL) and circular
polarized luminescence (CPL) scan must be measured, examples of 0.3 mm
[Eu(dpa)J][TMAh in [L-alanineC1][Tf2N] were overlaid in Figure 3.1.4. Following this
the resulting dissymmetry factor was calculated using equation 3.1.
C3.1)
The circular polarized luminescence magnitude was measured as the difference in left
and right rotated light intensity, !tCA) - IRCA). The total luminescence (TL) from the
europium sample effectively sum of the polarized intensities, ILCA) + IRCA). Using these
measurements the dissymmetry factor or gem CA) is calculated. The dissymmetry factor
allows for the CPL output to be related with varying TL. The dissymmetry factor
equalizes the difference in the scale of emission that is observed in each CIL, and was a
better metric of the chiral emission composition than the CPL magnitude alone. The
dissymmetry factor allowed measurement of differences in the chiral influence of the
racemization equilibrium in each CIL.
Analysis of the TL and CPL scans in both Figure 3.1.4, of 0.3 mm [Eutdpaji] [TMAh in
[L-alanineCl][Tt2N], and Figure 3.1.5, 0[0.3 mm [Eu(dpa)3][TMAb in [D-
alanineC1] [Tf2N] , indicated small signatures of the europium complex's lanthanide
electronic transitions. Europium emits at wavelengths 588 and 595 nm (as well as 615nm,
but not shown here). The TL scan, in Figure 3.1.4, had a small shoulder coming directly
before the main emission. The general spectra form was consistent with spectra measured
for the europium complex in other solutions. The previously discussed peaks merge
together, and only one gemcalculation was made corresponding to the main 593 11mpeak.
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Figure 3.1.5: TL (black) and CPL (red) scans for 0.3 mm [Eu(dpa)J][TMA b in [D-
alanineC 1][Tf2N] CIL.
Changes in the chiral influence by the CIL on the europium complex were seen in the
CPL scan through changes in magnitude and sign. Figure 3.1.5 shows how the [D-
alaninefl l jj'Tfj'N] CIL affected the europium complex with the same magnitude but with
opposite sign as [L-alanineC 1][Tt2N] in Figure 3.1.4. Also, the same europium signature
was measured in Figure 3.1.5 immediately prior to the main peak. Again, changes were
seen in the magnitude of both the CPL and TL scans allowing for inferences to be drawn
about how the CIL changes the chirality of the europium complex in the system.
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3.2 Discussing Dissymmetry Factor
Table 3.2.1 and 3.2.2 present numerical data of the CIL dissymmetry factors at changing
concentration of the europium complex as shown.
Table 3.2.1: Concentration dependent gemvalues for [Eu(dpa)3][TMA b in each CIL.
Concentration [L-alanineC 1r [D-alanineC 1r [L-leucineC 1r [L-prolineC 1r
(mm)
0.04
0.1 0.006 -0.005 -0.003 0.011
0.21 0.01 -0.016 0.004 0.01
0.3 0.011 -0.016 0.005
0.4 0.017 -0.022 0.013 0.005
0.5 -0.017
0.6 0.016 -0.013 0.006
0.96 0.015
Table 3.2.2: Concentration Dependent gemvalues for [Eu(dpa)3][TBAb in each CIL.
Concentration [L-alanineC 1r [D- [L- [L-
(mm) alanineCl r leucinef.l ]" prolinef.I]"
0.04
0.1 0.004 -0.01 -0.01 0.016
0.21 0.005 0.0025
0.3 0.008 -0.015 0.006
0.4 0.012 -0.007 0.008 0.011
0.5
0.6 0.006
0.96
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[L-alanineC 1]+ and [D-alanineC 1]+ at varying concentration of [Eufdpa)3] [TMA]3
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Figure 3.2.1: g<!mvalues for [L-alanineC 1][Tf2N] (black) and [D-alanineC 1][Tt2N] (red)
CILs with varying concentrations of [Eu(dpa)3][TMAb·
As shown in Figure 3.2.1, when using [L-alanineC 1][Tf2N] and [D-alanineC 1][Tf2N] the
[Eu(dpa)3][TMAh dissymmetry values followed similar magnitude trends with opposite
sign. The opposite sign was due to [L-alanineC 1][Tt2N] and [D-alanineC 1][Tt2N] , the
chiral influencing agent, favoring the opposite handedness. The europium complex
sensed a different chirality in each CIL, which was imposed at carbon-2 of the amino acid
cation (see Figure 1.1.1). The inf1uence of the CIL solvent selectively stabilized one
enantiomer of europium over the other. By stabilizing one enantiomer the 50:50 typical
equilibrium ratio was perturbed and the equilibrium shifted away from an equal, racemic
mixture.
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Figure 3.2.1 also presented dissymmetry values at 0.4 mm, showed a possible change in
the interaction of the europium complex with the chiral solvent. Figure 1.2.3 showed two
different symmetry axes for the europium complex. The two symmetry axes provide two
possible locations for the ClL to orient. Those orientations would likely have different
ability to chirally resolve the solute by the solvent. Changing the concentration of the
europium complex could have changed the ordering of the ClL that surrounded the
europium complex, and changed the ability for chiral perturbation. This peak in
dissymmetry may suggest a change in the chiral sense mechanism seen when
concentration was varied and possibly linked with the degree of chiral resolve by a
specific orientations of ClLs at each symmetry axes.
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[L-alanineCl][Tf2N] with [Eu(dpa)3][TBA]3 and [Eu(dpa)3][TMA]3
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Figure 3.2.2: Observed dissymmetry values at varying concentration of [Eutdpajrjl X],
(where rxj'- [TMAt (black) or [TBAt (red)) in [L-alanineCl][Tt2N].
The observed dissymmetry values increased as both concentration of [Eutdpan] [TMAh
and [Eu(dpa)3][TBAh increased, Figure 3.2.2. Concentrations above 0.4 mm for the
[Eu(dpa)3][TBAh solute was not measured because loss of solubility with the [TBAt
counter ion. [Eu(dpa)3][TMAh was still soluble after 0.4 mm concentrations. It was
proposed that the difference in solubility was based on the size difference in the
ammonium counter ion. [TBAt was significantly larger than the [TMAt cation, and
may be the cause for the difference in solubility. Insolubility was visually seen and could
be determined with both lifetime and phosphorescence scans.
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Figure 3.2.2 showed that [Eu(dpa)3][TMAh constantly gives a larger magnitude
dissymmetry factor than [Eu(dpa)3][TBAh. The difference between these magnitude was
possibly reflected by the size difference between [TMAt and [TBAt· The [TMAt
counter ion was much smaller and would be less likely to 'interrupt' interaction of the
Cll. with the europium complex. With a more constant, smaller counter ion disturbance,
it was assumed that there was more stabilization and therefore an increased dissymmetry
factor.
The dissymmetry factor shown for [Eu(dpa)3][TBAh and [Eu(dpa)3][TMAh both were
initially increasing with increasing concentration. The increase is observed for both
europium complexes up to 0.4 mm. Only the [Eu(dpa)3][TMAh complex can be
considered past that concentration. Following the 0.4 mm inflection point the
dissymmetry factor of [Eutdpa)«] [TMAh begins to decrease. The decreasing
dissymmetry value continued for the rest of the concentrations studied.
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Figure 3.2.3: Dissymmetry values at varying concentrations (mm) of [Eu(dpa)3][TMAb
in [L-leucineC 1][Tf2N] CIL.
When [L-leucineCl][Tf2_N] was employed as the CIL and [Eu(dpa)3][TMAb as the solute
(Figure 3.2.3) the dissymmetry value trend first observed in the [L-alanineClt and [D-
alaninef.l ]" CIL was observed. An increasing magnitude of the dissymmetry to 0.4 mm,
and then a subsequent decrease in dissymmetry was observed at concentration greater
than 0.4 mm. In [L-leucineCl][Tf2N] the [Eu(dpa)3][TMAb dissymmetry values began in
the negative region when at low concentrations.
Because the dissymmetry factor changes from a negative to a positive value it is
theorized that there was a change in chiral stabilization of the solution. At 0.1 mm the
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CIL molecules stabilized one enantiomer of the complex, while at 0.2 mm the other was
stabilized. It was concluded that the enantiomer stabilized in the CIL had changed but the
actual chiral solvent had not. The same phenomenon was replicated by using the chiral
enantiomers: [Dcalaninet.ll ]" and [Lealaninef.I]". Therefore it is interesting to find that a
single ionic liquid oriented itself in a manner that changed the stabilization mechanism.
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Figure 3.2.4: Dissymmetry values at varying concentrations (mm) of [Eufdpajj] [TBAb
in [L-IeucineC 1][Tt2N] CIL.
In Figure 3.2.4 [L-leucineCl][T6N] CIL and [Eu(dpa)3][TBAh shows again an increase
in dissymmetry was observed to a maximum concentration at 0.4 mm and then a
subsequent decrease was observed. A similar trend was seen for the europium complexes
in [L-leucineC 1][Tf2N], [L-alanineC 1][Tt2N] and [D-alanineC 1][Tf2N]. The
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dissymmetry factor began at a negative value and moved to a positive value indicating a
change in the europium enantiomer stabilized, observed with [Eu(dpa)3][TMAh in [L-
leucineCl][Tf2N] (Figure 3.2.3).
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Figure 3.2.5: Dissymmetry values at varying concentrations (mm) of [Eu(dpa)3][TMAh
in [L-prolineC 1][Tf2N] CIL.
[L-prolineC 1][Tf2N] dissymmetry trends (Figure 3.2.5) were different than those
observed with [L-alanineCl][Tf2N], [D-alanineCIHTf2N], and [L-leucineCl][Tt2N]. The
dissymmetry value decreased until 0.4 mm and then continued to increase at higher
concentrations. As the concentration of the europium complex, or the chiral effector,
increased we saw a decrease in the amount of chiral int1uence, as proposed by Pfeiffer
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effect Iiteraturev'. The unique behavior seen by [L-prolineCl][Tf2N] could be due to
structural differences compared to the other CILs. [L-prolineC 1][Tt2N] has a rigid, ring
structure. It may be possible for this structure to allow a unique interaction with the
europium complex, unseen in the interactions with the chain alkyl groups of the other
ClLs.
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Figure 3.2.6: Dissymmetry values at varying concentrations (mm) of [Eu(dpa)3][TBAb
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in [L-prolineC 1HTt2N] ClL.
When using [L-prolineCl][Tf2N] with [Eu(dpa)3][TBAh (Figure 3.2.6) the observed
trend in the dissymmetry matched that of [Eu( dpa)3HTMA bin [L-prolineC 1][Tf2N].
Again, the dissymmetry decreased until it reached 0.3 mm, and then increased. We were
unable to reach the same concentration range using [Eu(dpa)3][TBAb as with the other
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europium complex, because of decreased solubility. With the limited concentration range
we were still able to measure the same general form shown by the [Eu(dpa)3][TMA]J
complex. Again it was possible that the difference in [L-prolineCl][Tt2N] was that the
amino acid methyl ester possessed a rigid structure. This may have caused the unique and
different dissymmetry trend not observed in the other ClLs.
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3. 3 Temperature Dependence
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Figure 3.3.1: Total luminescence (TL) scan taken at variable temperature, indicated in the
legend (given in °C), of the [Eu(dpa)3][TMA]3 in [L-proCl][Tf2N].
Temperature dependence studies were completed in the consecutive order of TL scan
followed by a CPL scan. The direction of temperature change was varied to investigate
possible photobleaching occurrences over the long periods of exposure light. No
photobleaching was observed in the samples studied. The TL scans shown in Figure 3.3.1
of [Eurdpaj-] [TMAh in [L-proCI][Tf2N], showed a decrease in the TL with increasing
temperature. It appeared that the magnitude of absolute difference between consecutive
temperature changes decreased at higher temperatures. This was also observed in the
CPL scan shown in Figure 3.3.2.
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Figure 3.3.2: Circular polarized luminescence scans at variable temperature, indicated in
the legend (given at °C), of the [Eu(dpa)3][™Ab in [L-proCl][Tf2N].
CPL scans of [Eu( dpa)3][TMA h in [L-proC 1][Tf2N] at variable temperature were
collected and results shown in Figure 3.3.2. It appeared that as the temperature increased
the chiral luminescence measured by the CPL scan decreased. The change in magnitude
of this decrease in CPL seemed again to slow as the temperature was increased. This
same trend was shown in the TL scan in Figure 3.3.1. In both cases the decreasing
emission with increasing temperature may have been due to an increase in non-radiative
decay. The lifetime of initial intensity of [Eu(dpa)3][TBAb in [D-alanineCl][TfzN]
(Figure 3.3.3) decreased as the temperature increased, while the lifetime was nearly
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constant. Likewise, there was no observable pattern in any of the lifetime of any other
CILs.
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Figure 3.3.3: Lifetime spectra taken of [Eu(dpaji] [TBAh in [D-alanineC 1][Tt2N] at
variable temperature: 10° C (black), 200 C (red), 300 C (green), 400 C (blue), and 50
0
C
(purple).
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Figure 3.3.4 Dissymmetry (gem)values at varying temperature for [Eu(dpa)3][TMAh in
[L-proCl][Tf2N].
For all of the temperature dependent CPL and TL scans of [Eu(dpa)3][TMA]J in [L-
proC 1][Tt2N], dissymmetry factors were determined (Figure 3.3.4). These dissymmetry
factors have been transformed into equilibrium constants shown in equation 3.2:
3.2
This equation can be further understood by converting the measured gemto enantiomeric
excess values, 1']. The enantiomeric excess was calculated by dividing the gemvalue
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(gem (A) by the maximum possible dissymmetry for [Eu(dpa)r3, which was g~m(A) =
0.29.23 The enantiomeric excess was defined in equation 3.3:
gem (A)
1]= g~m(A)
3.3
The value of the enantiomeric excess can be transformed into a racemization equilibrium
constant, Krac, for [Eu(dpa)3r3, as shown in equation 3.4:
1+1]
Krac = 1 -1] 3.4
The van't Hoff equation (equation 3.5) was used to determine the heat of reaction (~H)
for the racemization. A plot of the natural log of the equilibrium term, Krac, against the
inverse temperature (T) formed the van't Hoff plot (Figure 3.3.5). The slope of the line is
defined as the heat of reaction divided by the gas law constant. This same procedure was
carried out for the other elL's containing [Eu(dpa)3][TMAh and were summarized in a
table 3.3.
!JH 1 !JS
In Krac = -RY+R 3.5
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Figure 3.3.5: Van't hoff plots for [Eu(dpa)3][TMAh in labeled CIL. Note CIL labeling is
reduced for legend, therefore "LprolineC 1"=[L-prolineC 1][Tf2N].
Table 3.3.1: Van't Hoff equation for all [Eu(dpa)3][TMA] sample in CIL, followed by the
extrapolated ~Hrac values.
Error:~Hrac
0.85 kJ/mol 0.116 kJ/mol
-0.58 kJ/mol 0.1010 kJ/mol
~O kJ/mol 0.1001 kJ/mol
1.36 kJ/mol 0.18 kJ/mol
0.7 kJ/mol
-0.7 kJ/mol
0.0 kJ/mol
0.7 kJ/mol
38
-The ~Hrac of [L-prolineCl][T6N] was an order of magnitude greater than the other heat
of reaction values. The large heat of reaction could be attributed to [L-prolineC 1t rigid
ring structure. The ligand arms of the europium complex could be wedged or locked in
place with the rigid ring, similar to the hydrophobic interactions hypothesized by
Brittairr". That "lock" could have provided a barrier to racemization. [L-prolineC 1]
[Tf2N] appeared to provide resistance to the racemization of europium, giving a positive
~H.
Another interesting finding was the ~H of the europium complex when in [L-
leucineCl][Tf2N]. Kroupa et al. cited the unique environment that [L-leucineCl][Tf2N]
created for the europium racemization, as the temperature didn't effect the
[Eu(dpa)3][TBAh racemization equilibrium constant. Within the error the [L-
leucineC 1][Tf2N] ClL showed a ~Hrac= 0 kl/mol, This thesis reassures that [L-
leucineC 1][Tf2N] does not enthalpically favor one enantiomer of [Eu(dpa)3][TMA hover
the other, as the slope of the van't Hoff plot was O.
It should be noted that the coefficient of determination (R2), shown in Table 3.3.1, for
these van't Hoff plots were poor except for [Eu(dpa)3][TMAb in [L-prolineCl][Tf2N].
The data should be collected in smaller temperature intervals to ensure the temperature
dependence.
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Because of this future studies should also look into how the counter ion ([TMA r and
[TBA t) effect the perturbation of the europium probe. It may be possible to use some
computer modeling to answer the role of the counter ion. Additional chiral environment
molecules may create a tailored chiral sense in the europium complex? If this is the case
it may be possible to create tailored chiral affecting liquids.
3.4 Conclusion
CILs have the ability to influence the racemization equilibrium of lanthanide complexes,
[Eu(dpa)3][TMAh and [Eu(dpa)3][TBAb- Previously it was found that these influences
were temperature dependent, showing an enthalpic effect." In this work it was
determined that there was also a concentration dependence. The concentration
dependence of the europium complex in [L-prolineCl][Tf2N] and [L-leucineCl][TtzN]
were unique when compared to the other ClLs, and it was proposed that structural
differences may be the cause of this difference.
Van't Hoff determination of ~Hrac = 1.141 kl/mol and 0.0 kllmol for [Eu(dpa)3][TMAh
in [L-prolineCl][TtzN] and [L-leucineCl][TtzN] respectively. The large heat of
racemization observed for the solute in [L-prolineCl ][Tt2N] may be due to the rigid ring
structure. The structure may allow intermolecular bonds strong enough to influence the
chirality of the solute. That strong enthalpic motivation may explain the unique
concentration dependence observed in the dissymmetries. The weak intermolecular
enthalpic motivation seen for the solute in [L-leucineC 1][Tf2N] could describe the unique
concentration dependence also. For [L-leucineC 1][Tf2N], it was proposed that the M-Irac =
40
-
o kJ/mol, meaning that the intermolecular bonding between one enantiomer and the Cll,
molecules was no stronger than the Cll. with the other enantiomer. This proposes that
any change in the racemization is enacted from the change in entropy based on the
concentration.
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4 Appendix
4.1 Emission Spectra
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Figure 4.1.1: Fluorescence scan of 0.4 mm [Eu(dpa)3][TMAh in [D-alanineCl][Ti2N].
Slit width: 5.
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Figure 4.1.2: Phosphorescence scan of 0.6 mm [Eu(dpa)3][TMAh in [L-
alanineCIHTf2N]. Slit width: 2.S.
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Figure 4.1.3: Phosphorescence scan of 0.6 11'1111 [Eu(dpa)3][TMA h in [D-
alanineCl][Tt2N]. Slit width: S.
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Figure 4.l.3: Phosphorescence scan of 0.4 mm [Eu(dpa)3][TMAh in [D-
alanineCl][Tf2N]. Slit width: 5.~~ __-r--~--.---~--.--.---r---'--'---'--'
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Figure 4.1.4: Phosphorescence scan of 0.3 mm [Eu(dpa)3][TBAb in [L-leucineCl][Tt2_N].
Slit width: 2.5.
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Figure 4.1.5: Phosphorescence scan 0[0.6 mm [Eu(dpa)3][TMAb in [L-
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Figure 4.1.6: Phosphorescence scan of 0.1 mm [Eu(dpa)3][TMAh in [L-
prolineCl][Tf2N]. Slit width: 2.5.
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Figure 4.1.7: Phosphorescence scan of 0.2 mm [Eu(dpa)3][TMA]J in [L-
prolineCl][Tf2N]. Slit width: 2.5.
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Figure 4.1.8: Phosphorescence scan of 0.3 mm [Eu(dpa)3][TMAh in [L-
prolineCl][Tf2N]. Slit width: 2.5.
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Figure 4.1.9: Phosphorescence scan of 0.4 mm [Eu(dpa)3][TMAh in [L-
prolineCl][Tf2N]. Slit width: 2.5.
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4.2 Lifetime Spectra
1.4
1.2
1.0
0.8
>-:t:::enc 0.6
Q.)......c
0.4
Chih2/DoF = 0.00055
Rh2 = 0.99523
yO 0 ±O
A1 1.29919
t1 1.75947
±O.00228
±O.00455
° 2 3 4t (ms)
Figure 4.2.1: Lifetime scan 01'0.1 mm [Eu(dpa)3][TMAh in [L-alanineC1][Tf2N).
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Figure 4.2.2: Lifetime scan of 0.2 mm [Eu(dpa)3][TMA]3 in [L-alanineCl][Tf2N].
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Figure 4.2.4: Lifetime scan of 0.4 mm [Eu(dpa)3][TMAh in [L_alanineCl][Tf,Nl
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Figure 4.2.5: Lifetime scan of 0.4 mm [Eu(dpa) 3][TBA]J in [L-a1anineC
1
][Tf,N].
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Figure 4.2.6: Lifetime scan of 0.2 mm [Eu(dpa)3][TMA], in [D_alanineCl][TtiNJ.
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Figure 4.2.7: Lifetime scan of 0.3 mm [Eu(dpa)3][TMAh in [D_alanineCI][Tf2
N
J.
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Figure 4.2.8: Lifetime scan of 0.4 mm [Eu(dpah][TMAh in [D-alanineCI ][Tf2NJ.
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Figure 4.2.9: Lifetime scan of 0.6 mm [Eu(dpa)3][TMAb in [D-alanineCl][Tf2N].2.5 ~_....-___, _ __,._ .........._--r-_--r-_-r-_-.-_-r--_....---'_---'
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Figure 4.2.10: Lifetime scan of 0.1 mm [Eu(dpa)3][TBAh in [D-alanineC1][Tf2N].
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Figure 4.2. 11: Lifetime scan of 0.1 mm [Eu(dp'),] [TMAh in [L-pro1ineC
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Figure 4.2.12: Lifetime scan of 0.2 mm [Eu(dpa): ][TMA], in [L-pro1ineC1][Tf,N].
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Figure 4.2.13: Lifetime scan of 0.3 mm [Eu(dpa)3][TMAh in [L_prolineCl][TtiN].
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Figure 4.2.14: Lifetime scan ofOA mm [Eu(dpa)3lf™Ah in [L_prolineClllTf,N].
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Figure 4.2.15: Lifetime scan of 0.1 mm [Eu(dpa)3][TBAh in [L-prolineCI][Tf2N].
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Figure 4.2.16: Lifetime scan of 0.3 mm [Eu(dpa)3][TBA]J in [L-prolineCl][TfzN].
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Figure 4.2.17: Lifetime scan of 0.2 mm [Eu(dpa)3][TMAb in [L-leucineCl][Tt2N].
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Figure 4.2.18: Lifetime scan of 0.2 mm [Eu(dpa)3][TBAb in [L-leucineCl][Tt2N].
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Figure 4.2.19: Lifetime scan of 0.6 mID [Eu(dpah][TBAh in [L_leucineCI][Tf,Nj.
4.3 Total Luminescence and Circular Polarized Luminescence Spectra
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Figure 4.3.1: TLlCPL overlay 0[0.1 mm [Eu(dpa)3][TMAb in [L-alanineCl][Tf2N].
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Figure 4.3.2: TLlCPL overlay of 0.2 mm [Eu(dpa)3J[TMAb in [L-alanineCl][T6N].
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Figure 4.3.3: TLlCPL overlay 0[0.3 mm [Eu(dpa)3][TMAh in [L-alanineCl][T6N].
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Figure 4.3.4: TLlCPL overlay 0[0.4 mm [Eu(dpa)3][TMAh in [L-alanineCl][TfzN].
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Figure 4.3.5: TLlCPL overlay of 0.6 mm [Eu(dpa)3] [TMAh_ in [L-alanineCl][Tt2N].
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Figure 4.3.6: TLlCPL overlay of 0.1 mm [Eu(dpa)3][TBAh in [L-alanineCl][Tt2N].
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Figure 4.3.7: TLlCPL overlay of 0.2 mm [Eu(dpa)3][TBAh in [L-alanineCl][T6N].
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Figure 4.3.8: TLlCPL overlay of 0.3 mm [Eu(dpa)3][TBAh in [L-alanineCl][Tf2N].
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Figure 4.3.9: TLlCPL overlay of 0.4 mm [Eu(dpa)3][TBAh in [L-alanineCl][Tf2N].
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Figure 4.3.10: TLlCPL overlay of 0.2 mm [Eu(dpa)3][TMAh in [D-alanineCl][Tt2N].
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Figure 4.3.11: TLlCPL overlay of 0.3 mm [Eu(dpa)3][TMAh in [D-alanineCl][Tf2N].
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Figure 4.3.12: TLlCPL overlay of 0.4 mm [Eu(dpa)3][TMAh in [D-alanineCl][Tf2N].
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Figure 4.3.13: TLlCPL overlay 0[0.5 mm [Eu(dpa)3J[TMAh in [D_alanineCI][Tti
N
].
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Figure 4.3.14: TLlCPL overlay 0[0.6 mm [Eu(dpa)3][TMA]J in lD-alanineCIJ[Tf,NJ.
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Figure 4.3.15: TLlCPL overlay of 0.1 mm [Eu(dpa)3][TBA]3 in [D-alanineCl][Tf2N].
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Figure 4.3.16: TLlCPL overlay 01'0.1 mm [Eu(dpa)3][TMA]3 in [L-prolineCl][Tt2N].
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Figure 4.3.17: TLlCPL overlay of 0.2 mm [Eu(dpa)3][TMAh in [L-prolineC1][Tf2N].
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Figure 4.3.18: TLlCPL overlay of 0.3 mm [Eu(dpa)3][TMAh in [L-prolineC1][Tf2N].
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Figure 4.3.19: TLlCPL overlay ofOA mm [Eu(dpa)3][TMA]J in [L_prolineCI][Tf2N].
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Figure 4.3.20: TLlCPL overlay of 0.6 mm [Eu(dpa)J][TMAh in [L_prolineCl][Tf,NJ,
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Figure 4.3.21: TLlCPL overlay of 0.1 mm [Eu(dpa)3][TBAh in [L-prolineCl][Tf2N].
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Figure 4.3.22: TLlCPL overlay of 0.3 mm [Eu(dpa)3][TBAh in [L-prolineCl][Tf2N].
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Figure 4.3.23: TLlCPL overlay of 0.4 mm [Eu(dpa)3][TBAh in [L-prolineC1][Tf2N].
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Figure 4.3.24: TLlCPL overlay of 0.1 mm [Eu(dpa)3][TMAh in [L-IeucineCl][Tt2N].
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Figure 4.3.25: TLlCPL overlay of 0.2 mm [Eu(dpa)3][TMAh in [L-leucineCl][TtiN].
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Figure 4.3.26: TLlCPL overlay 0[004 mm [Eu(dpa)3][TMAb in [L-leucineCl][TtiN].
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Figure 4.3.27: TLlCPL overlay 0[0.6 mID [Eu(dpa)3][TMA]J in [L_leucineCl][TfzNJ.
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Figure 4.3.28: TLlCPL overlay of 0.2 mm [Eu(dpa)3][TBAh in lL_]eucineCl][Tf,NJ.
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Figure 4.3.29: TLiCPL overlay of 0.3 mm [Eu(dpa)3][TBA], in [L-leucineCl][Tf,NJ.
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Figure 4.3.30: TLiCPL overlay of 0.4 mm [Eu(dpa)3][TBA]3 in [L_leucin
eC1
]lTli
N
J.
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Figure 4.3.31: TLlCPL overlay of 0.6 mm [Eu(dpa)3][TBAh in [L-leucineC1][Tf2N].
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4.4 Temperature Dependent Data
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Figure 4.4.1: CPL scan of [Eu(dpaji] [TMA 13 in [L-alanineC 1][Tf2N] at variable
temperature 300 ~~~~~~~'--r~--r-~~-'~--~'-~~~~------
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Figure 4.4.2: CPL scan of [Eu(dpa)3][TMA 13 in [D-alanineC 1][Tt2N] at variable
temperature
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Figure 4.4.3: CPL scan of [Eutdpa)s] [TMAh in [L-prolineCl][Tf2N] at variable
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Figure 4.4.4: CPL scan of [Eutdpajj] [TMAh in [L-leucineCl ][Tt2N] at variable
temperature.
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Figure 4.4.5: TL scan of [Eu(dpa)3][TMA h in [L-alanineC 1][Tf2N] at variable
temperature.
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Figure 4.4.6: TL scan of [Eu(dpa)3][TMAh in [D-alanineCl][Tf2N] at variable
temperature.
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Figure 4.4.7: TL scan of [Eu(dpa)3] [TMAh in [L-prolineCl][Tf2N] at variable
temperature.
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Figure 4.4.8: TL scan of [Eu(dpa)3][TMAh in [L-leucineCl][Tf2N] at variable
temperature.
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Figure 4.4.9: gemplot of [Eu(dpa)3][TBAh in [L-alanineCl][Tf2N] at variable
temperature.
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Figure 4.4.10: gemplot of[Eu(dpa)3][TBAh in [D-alanineCl][Tt2N] at variable
temperature.
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Figure 4.4.11: gemplot of [Eu(dpa)«] [TBAh in [L-prolineC 1][Tf2N] at variable
temperature.
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Figure 4.4.12: gemplot of [Eu(dpa)3][TBAh in [L-leucineC 1][Tf2N] at variable
temperature.
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Figure 4.4.13: van't Hoff plot of [Eu(dpa)3][TBA h in [L-alanineC 1][Tf2N].
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Figure 4.4.14: van't Hoff plot of [Eutdpa)-] [TBAh in [D-alanineCl ][Tf2N].
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Figure 4.4.15: van't Hoff plot of [Eu(dpa)3][TBAh in [L-prolineCl][Tf2N].
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Figure 4.4.16: van't Hoff plot of [Eurdpalr] [TBAb in [L-leucineCl][Tt2N].
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